Essential Thrombocythaemia

Essential Thrombocythaemia (ET) is a disorder of the blood which can be seen in both males and females and at all ages but is more often seen in older patient (>60years). Often there are no symptoms for ET and it is often detected through routine blood tests.

ET is due to an abnormally high platelet level in the blood. Platelets are tiny colourless disc shaped particles. Platelets play an important role in the clotting of the blood, generally in response to injury. These particles stick together and form a plug to stop blood leaking from small blood vessels.

The major risk for people with ET is thrombosis (excessive clotting of the blood which may block an artery or vein).

Agrylin® (anagrelide hydrochloride)

Agrylin is used to stop the bone marrow from producing too many platelets. The way in which Agrylin works is not clearly understood.

Agrylin is indicated for the treatment of Essential Thrombocythaemia.

Click here to access CMI

Any information provided should be discussed with your health care professional and should not replace their advice.